Healthcare
PPM Oost sells Pharmaline to Gilde Healthcare Partners
PPM Oost has sold its stake in Dutch medical supplies company Pharmaline to Gilde Healthcare Partners.
Sovereign's City & County buys ISS Healthcare
Sovereign Capital portfolio company City & County Healthcare Group has bought Welsh business ISS Healthcare in what marks its 14th acquisition since 2009.
Forbion Capital et al. back Dezima Pharma
Forbion Capital Partners and BioGeneration Ventures have led a €9.8m series-A funding round for Dutch biotechnology company Dezima Pharma.
Gimv launches Health & Care Fund
Gimv has launched a new €200m fund focused on healthcare and medical technology investments.
Inkef invests €7.5m in Sapiens
Inkef Capital has invested €7.5m in Dutch medical technology company Sapiens Steering Brain Stimulation (Sapiens), extending the company's series-A funding.
Amadeus Capital Partners backs Bellco
Amadeus Capital Partners has entered the shareholding of Italian dialysis technology company Bellco, owned by Montezemolo & Partners.
PE-backed Labco in €100m high-yield refinancing
French medical diagnostics company Labco has made a €100m bond issue to repay the outstanding amounts borrowed under its revolving credit facility.
CBPE sells Rosemont Pharmaceuticals to Perrigo
CBPE Capital has sold Leeds-based pharma company Rosemont Pharmaceuticals to US trade buyer Perrigo Company.
Gimv et al. invest €5.5m in pharma company Multiplicom
Gimv and regional Belgian players have invested €5.5m in Antwerp-based biotechnology company Multiplicom NV.
CRB and Inveready back Amadix
Spanish VC investors CRB Inverbio and Inveready have injected €2m into biotech firm Amadix.
Albion backs healthcare software firm MyMeds&Me
Albion Ventures has invested ТЃ2m in British healthcare software-as-a-service (SaaS) business MyMeds&Me.
Cinven-backed Spire Healthcare pays down debt
Cinven-backed Spire Healthcare has sold off 12 of its 38 hospitals in a bid to raise cash to reduce the large bank debt on its books.
Baxter Ventures invests €2m in Zytoprotec
Baxter Ventures has invested €2m as part of a €4m series-A round for Vienna-based biotech company Zytoprotec.
Waterland's RHM Kliniken acquires Heinrich Mann clinic
RHM Kliniken, a healthcare provider backed by Waterland Private Equity Investments, has acquired the Heinrich Mann clinic as part of its buy-and-build strategy.
Omnes Capital et al. invest in Medisse
IIG (Innovatie- en Investeringsfonds Gelderland), BioGeneration Ventures and Omnes Capital have invested €2.6m in Dutch pharmaceuticals company Medisse.
Nausicaa Ventures et al. invest €7.7m in Bone Therapeutics
Existing investors and two new regional backers have committed €7.7m to Belgian pharmaceuticals company Bone Therapeutics.
Sigma Gestion invests €1.5m in Sogemed
Sigma Gestion has provided French second-hand medical equipment dealer Sogemed with €1.5m of funding.
Unilever and FF&P exit BAC BV
Unilever Ventures and FF&P Private Equity have sold BAC BV, which specialises in affinity purification of biological materials, to Life Technologies Corporation.
Midven in second round for Fertility Focus
Midven has joined angel investors in a seven-figure funding round for fertility diagnosis and treatment firm Fertility Focus.
NBGI's Horizon Care acquires Educare
NBGI Private Equity-backed specialist care provider Horizon Care has acquired care and education business Educare Adolescent Services Ltd.
Gimv et al. invest €5m in biotech startup AgroSavfe
Gimv has led a €5m investment in Belgian green crop protection products business AgroSavfe, alongside regional funds PMV, Sofi, QBIC and VIB.
ADM Capital et al. looking to exit Turkish hospital
An investor group including ADM Capital, Dutch pension fund PGGM and the International Finance Corporation (IFC) are looking to exit Turkish hospital chain Universal Saglik Yatirimlari, according to reports.
Rutland reaps 2.6x on Advantage Healthcare sale
Rutland Partners has sold UK-based Advantage Healthcare to trade buyer Interserve for ТЃ26.5m, making a 2.6x money multiple on its original investment.
HTGF backs Drug Response Dx
High-Tech Gründerfonds (HTGF) has backed German biotechnology start-up Drug Response Dx (DRDx), in what marks the company's first round of funding.